Patent History
  • Application
    US 11/262044 2005-10-28
  • Publication
    US 2006110758 2006-05-25

published patent: Synthetic Peptide Targeting Critical Sites On The Sars-Associated Coronavirus Spike Protein Responsible For Viral Infection And Method Of Use Thereof

TitleSynthetic Peptide Targeting Critical Sites On The Sars-Associated Coronavirus Spike Protein Responsible For Viral Infection And Method Of Use Thereof
Priority Date2005-10-28 US 11/262044
2004-11-22 US 11/630334P
Inventors
Issue Date2006
Citation
US Published patent application 2006110758. Washington, DC: US Patent and Trademark Office (USPTO), 2006 How to Cite?
AbstractThe Present Invention Provides Methods For Locating Critical Portions Or Sites On The Spike Protein (S Protein) Of Sars-Associated Coronavirus (Sars-Cov) Responsible For The Viral Infection That Causes Severe Acute Respiratory Syndrome (Sars). The Present Invention Also Provides New Synthetic Peptides Targeting Such Critical Portions Or Sites Of The S Protein Of Sars-Cov For Preventing Or Treating Of Sars-Cov Infection In A Subject. The Present Invention Further Provides Methods Of Testing Antiviral Activity Exerted By Antiviral Agents Using Real-Time Quantitative Pcr.
Persistent Identifierhttp://hdl.handle.net/10722/45676

 

DC FieldValueLanguage
dc.date.accessioned2007-10-30T06:32:16Z-
dc.date.available2007-10-30T06:32:16Z-
dc.date.issued2006-
dc.identifier.citationUS Published patent application 2006110758. Washington, DC: US Patent and Trademark Office (USPTO), 2006en_HK
dc.identifier.urihttp://hdl.handle.net/10722/45676-
dc.description.abstractThe Present Invention Provides Methods For Locating Critical Portions Or Sites On The Spike Protein (S Protein) Of Sars-Associated Coronavirus (Sars-Cov) Responsible For The Viral Infection That Causes Severe Acute Respiratory Syndrome (Sars). The Present Invention Also Provides New Synthetic Peptides Targeting Such Critical Portions Or Sites Of The S Protein Of Sars-Cov For Preventing Or Treating Of Sars-Cov Infection In A Subject. The Present Invention Further Provides Methods Of Testing Antiviral Activity Exerted By Antiviral Agents Using Real-Time Quantitative Pcr.en_HK
dc.format.extent2119238 bytes-
dc.format.extent942075 bytes-
dc.format.extent2458 bytes-
dc.format.extent2713 bytes-
dc.format.mimetypeapplication/pdf-
dc.format.mimetypeapplication/pdf-
dc.format.mimetypetext/plain-
dc.format.mimetypetext/plain-
dc.languageengen_HK
dc.relation.isreferencedbyUS 2010093601 (A1) 2010-04-15en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents-
dc.titleSynthetic Peptide Targeting Critical Sites On The Sars-Associated Coronavirus Spike Protein Responsible For Viral Infection And Method Of Use Thereofen_HK
dc.typePatenten_HK
dc.description.naturepublished_or_final_versionen_HK
dc.contributor.inventorZheng, BJen_HK
dc.contributor.inventorGuan, Yen_HK
dc.contributor.inventorHuang, Jen_HK
dc.contributor.inventorHe, MLen_HK
patents.identifier.applicationUS 11/262044en_HK
patents.description.assigneeUniv Hong Kong [Cn]en_HK
patents.description.countryUnited States of Americaen_HK
patents.date.publication2006-05-25en_HK
patents.identifier.hkutechidMicro-2004-00170-1-
patents.date.application2005-10-28en_HK
patents.date.priority2005-10-28 US 11/262044en_HK
patents.date.priority2004-11-22 US 11/630334Pen_HK
patents.description.ccUSen_HK
patents.identifier.publicationUS 2006110758en_HK
patents.identifier.publicationUS 7491489-
patents.relation.familyCN 1815234 (A) 2006-08-09en_HK
patents.relation.familyUS 2006110758 (A1) 2006-05-25en_HK
patents.relation.familyUS 7491489 (B2) 2009-02-17en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats